Catalyst Wire Dossier Catalyst Wire Dossier

BI135585 XX

· Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BI135585 XX, covering 2013-11-01 to 2013-11-01. Get the full timeline:

Most recent: Clinical Trial Update: Trial to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Oral Doses of BI135585 XX Administered as Tablet and as Solution in Healthy Volunteers [Phase 1]

See pricing